Ignite Creation Date:
2024-05-06 @ 5:41 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05398406
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2022-05-17
Brief Title:
Subcostal Transversus Abdominus Erector Spinae and Paravertebral Blocks Effects on Laparoscopic Cholecystectomy Cases
Sponsor:
Yuzuncu Yıl University
Organization:
Yuzuncu Yıl University
Study Overview
Official Title:
Subcostal Transversus Abdominus Plane Block Erector Spinae Plane Block and Paravertebral Blocks Effects
Status:
COMPLETED
Status Verified Date:
2022-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sixty patients with ASA American Society of Anesthesiologist I-II physical status between the ages of 20-60 were randomized into three groups TAP block group Group T ESP block group Group E and PVB group Group P Bilateral 20cc total 40cc for each patient 025 bupivacaine was applied by ultrasound US guidance Intraoperative vital signs heart rate blood pressure and saturation Train-of-four TOF values additional dose of opioid and muscle relaxant needs complications were recorded Postoperative side effects nausea vomiting itching tremor the need for additional postoperative analgesia Visual Analog Scale VAS scores were noted
Detailed Description:
Cases under the age of 20 - over 60 emerge and bleeding outside the ASAI-II functional status undergo surgery other than laparoscopic cholecystectomy refused to participate in the study allergic to local anesthetic agents with a body mass index BMI 30 have contraindications for regional anesthesia sepsis local infection coagulopathy heart disease hypovolemia cases that do not want regional anesthesia pregnant were not included in the studyTwenty patients in each group and a total of 60 patients were included the study by power analysis According to the randomized single-blind closed-envelope method patients were randomly divided into three groups
Group T Subcostal TAP Block 40 cc 20cc20cc 025 Bupivacaine for bilateral application Group E ESP Block 40 cc 20cc20cc 025 Bupivacaine for bilateral application Group P PVB 40 cc 20cc20cc 025 Bupivacaine for bilateral application were prepared
Group T Subcostal TAP Block 40 cc 20cc20cc 025 Bupivacaine for bilateral application Group E ESP Block 40 cc 20cc20cc 025 Bupivacaine for bilateral application Group P PVB 40 cc 20cc20cc 025 Bupivacaine for bilateral application were prepared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None